Open Access
Unlocking the Potential of Vaccines Built on Messenger RNA
Author(s) -
Elena Locci,
Silvia Raymond
Publication year - 2021
Language(s) - English
DOI - 10.36811/jca.2021.110013
Subject(s) - immunotherapy , immune system , discontinuation , medicine , cancer immunotherapy , cancer , immunology , cancer treatment , cancer research
In recent years, immunotherapy has revolutionized the treatment of cancer; however, inflammatory reactions in healthy tissues often have side effects that can be serious and lead to permanent discontinuation of treatment. This toxicity is not yet well understood and is a major obstacle to the use of immunotherapy. When the immune system is so severely activated, the resulting inflammatory reaction can have detrimental effects and sometimes serious damage to healthy tissue. We wanted to know if there was a difference between an optimal immune response that aims to kill cancer and an unwanted response that could affect healthy tissue. Identifying the distinctive elements between these two immune responses allows the development of new, more effective and less toxic therapeutic approaches.Keywords: Cancer; Cells; Tissues, Tumors; Prevention, Prognosis; Diagnosis; Imaging; Screening; Treatment; Management